Acceptance and commitment group therapy (ACT-G) for health anxiety: A randomized controlled trial

Psychological Medicine

Volumn 46, Issue 1, 2016, Pages 103-115

  Eilenberg, T ^a   Fink, P ^a   Jensen, J S ^a   Rief, W ^b   Frostholm, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Acceptance and commitment therapy; health anxiety; hypochondriasis; illness anxiety disorder; randomized control trial

Indexed keywords

ACCEPTANCE AND COMMITMENT THERAPY; ADULT; ANXIETY DISORDERS; CONTROLLED STUDY; FEMALE; GROUP THERAPY; HUMAN; HYPOCHONDRIASIS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ACCEPTANCE AND COMMITMENT THERAPY; ADULT; ANXIETY DISORDERS; FEMALE; HUMANS; HYPOCHONDRIASIS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY, GROUP; YOUNG ADULT;

EID: 84949531041     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291715001579     Document Type: Article

References (33)

1. Arch JJ, Eifert GH, Davies C, Vilardaga JC, Rose RD, Craske MG (2012). Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders. Journal of Consuling and Clinical Psychology 80, 750-765.
2. Barsky AJ, Ahern DK (2004). Cognitive behavior therapy for hypochondriasis: A randomized controlled trial. Journal of the American Medical Association 291, 1464-1470.
3. Barsky AJ, Wyshak G, Klerman LG (1990a). Transient hypochondriasis. Archives of General Psychiatry 47, 746-752.
4. Barsky AJ, Wyshak G, Klerman LG, Latham KS (1990b). The prevalence of hypochondriasis in medical outpatients. Social Psychiatry and Psychiatric Epidemiology 25, 89-94.
5. Bjørner JB, Damsgaard MT, Watt T, Bech P, Rasmussen NK, Kristensen TS, Modvig J, Thunedborg K (2003). Dansk manual til SF-36-et spørgeskema om helbredsstatus. LIF Lægemiddelindustriforeningen, København.
6. Derogatis LR (2007). Dokument for den danske udgave af SCL-90-R. In SCL-90-R: Symptom checklist-90-R. Vejledning til administration og scoring, Psykologisk Forlag.
7. Derogatis LR, Cleary PA (1977). Confirmation of the dimensional structure of the SCL-90: A study in construct validation. Journal of Clinical Psychology 33, 981-989.
8. Eilenberg T, Kronstrand L, Fink P, Frostholm L (2013). Acceptance and commitment group therapy for health anxiety-Results from a pilot study. Journal of Anxiety Disorders 27, 461-468.
9. Fink P, Ewald H, Jensen J, Sorensen L, Engberg M, Holm M, Munk-Jørgensen P (1999). Screening for somatization and hypochondriasis in primary care and neurological in-patients: A seven-item scale for hypochondriasis and somatization. Journal of Psychosomatic Research 46, 261-273.
10. Fink P, Ornbøl E, Christensen KS (2010). The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health. PLoS ONE 5, e9873.
11. Fink P, Ornbøl E, Huyse FJ, de Jonge P, Lobo A, Herzog T, Slaets JPJ, Cardoso G, Arolt V, Rigatelli M, Hansen MS (2004a). A brief diagnostic screening instrument for mental disturbances in general medical wards. Journal of Psychosomatic Research 57, 17-24.
12. Fink P, Ornbøl E, Toft T, Sparle KC, Frostholm L, Olesen F (2004b). A new, empirically established hypochondriasis diagnosis. American Journal of Psychiatry 161, 1680-1691.
13. Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, Imai H, Chen P, Hunot V, Churchill R (2014). Waiting list may be a nocebo condition in psychotherapy trials: A contribution from network meta-analysis. Acta Psychiatry Scandinavia 130, 181-192.
14. Greeven A, van Balkom AJ, Spinhoven P (2014). Personality predicts time to remission and clinical status in hypochondriasis during a 6-year follow-up. Journal of Nervous and Mental Disease 202, 402-407.
15. Greeven A, van Balkom AJ, Visser S, Merkelbach JW, van Rood YR, Van Dyck R, van der Does AJ, Zitman FG, Spinhoven P (2007). Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: A randomized controlled trial. American Journal of Psychiatry 164, 91-99.
16. Gureje O, Ustun TB, Simon GE (1997). The syndrome of hypochondriasis: A cross-national study in primary care. Psychological Medicine 27, 1001-1010.
17. Hedman E, Andersson G, Andersson E, Ljotsson B, Ruck C, Asmundson GJ, Lindefors N (2011). Internet-based cognitivebehavioural therapy for severe health anxiety: randomised controlled trial. British Journal of Psychiatry 198, 230-236.
18. Hofmann SG, Asmundson GJ (2008). Acceptance and mindfulness-based therapy: new wave or old hat? Clinical Psychology Review 28, 1-16.
19. Jacobson NS, Truax P (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59, 12-19.
20. Kellner R, Schneider-Braus K (1988). Distress and attitudes in patients perceived as hypochondriacal by medical staff. General.Hospital.Psychiatry 10, 157-162.
21. McManus F, Surawy C, Muse K, Vazquez-Montes M, Williams JM (2012). A randomized clinical trial of mindfulness-based cognitive therapy versus unrestricted services for health anxiety (Hypochondriasis). Journal of Consulting and Clinical Psychology 80, 817-828.
22. Norman GR, Sloan JA, Wyrwich KW (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care 41, 582-592.
23. Olatunji BO, Kauffman BY, Meltzer S, Davis ML, Smits JA, Powers MB (2014). Cognitive-behavioral therapy for hypochondriasis/health anxiety: A meta-analysis of treatment outcome and moderators. Behavior.Research and. Therapy 58, 65-74.
24. Olde Hartman TC, Borghuis MS, Lucassen PL, van de Laar FA, Speckens AE, van WC (2009). Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. Journal of Psychosomatic Research 66, 363-377.
25. Perera R, Heneghan C, Yudkin P (2007). Graphical method for depicting randomised trials of complex interventions. British Medical Journal 334, 127-129.
26. Rosendal M, Bro F, Sokolowski I, Fink P, Toft T, Olesen F (2005). A randomised controlled trial of brief training in assessment and treatment of somatisation: effects on GPs' attitudes. Family Practice 22, 419-427.
27. Schroder A, Fink P, Fjorback LO, Frostholm L, Rosendal M (2010). Towards a unified treatment approach for functional somatic syndromes and somatization. Ugeskr.laeger 172, 1839-1842.
28. Swain J, Hancock K, Hainsworth C, Bowman J (2013). Acceptance and Commitment Therapy in the treatment of anxiety: A systematic review. Clinical Psychology Review 33, 965-978.
29. Thomson AB, Page LA (2007). Psychotherapies for hypochondriasis. Cochrane. Database of Systematic Reviews 4, CD006520.
30. Tyrer P, Cooper S, Salkovskis P, Tyrer H, Crawford M, Byford S, Dupont S, Finnis S, Green J, McLaren E, Murphy D, Reid S, Smith G, Wang D, Warwick H, Petkova H, Barrett B (2014). Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: A multicentre randomised controlled trial. Lancet 383, 219-225.
31. Ware JE, Kosinski M (2001). SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1, 2nd edn. Quality Metric Inc.: Lincoln, RI.
32. Weck F, Neng JM, Richtberg S, Jakob M, Stangier U (2015). Cognitive therapy versus exposure therapy for hypochondriasis (Health Anxiety): A randomized controlled trial. Journal of Anxiety Disorders 34, 1-7.
33. Wetherell JL, Afari N, Rutledge T, Sorrell JT, Stoddard JA, Petkus AJ, Solomon BC, Lehman DH, Liu L, Lang AJ, Atkinson JH (2011). A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain 152, 2098-2107.